MW

Markus Warmuth

Venture Partner at Versant Ventures

Cambridge, Massachusetts

Overview

Work Experience

VT

Ventus Therapeutics

  • Member Board Of Directors

    2021 - Current

MR

Monte Rosa Therapeutics

  • Chief Executive Officer

    2019

VV

Versant Ventures

  • Venture Partner

    2019

II

IMV Inc.

  • Independent Board Member

    2018 - 2023

TR

Third Rock Ventures

  • Entrepreneur In Residence

    2018 - 2019

RT

Relay Therapeutics

  • Independent Board Member

    2017 - 2018

H3 Biomedicine

  • President and Chief Executive Officer

    2011 - 2018

  • Chief Scientific Officer

    2011 - 2011

NI

Novartis Institutes for BioMedical Research (NIBR)

  • Executive Director and Head of Oncology Drug Dicovery

    2008 - 2011

LU

Ludwig-Maximilians Universität München

  • MD

    1998 - 2002

    Medical Oncologist and Principal Investigator

Education

Investments

Monte Rosa Therapeutics

Series A

Total Funding: $220M

Relevant Websites